Xeris Pharmaceuticals Secures $7,274,592 Series B Round

  • Feed Type
  • Date
    9/29/2014
  • Company Name
    Xeris Pharmaceuticals
  • Mailing Address
    3208 Red River Street Austin, TX 78705 USA
  • Company Description
    Xeris is an Austin, Texas-based specialty pharmaceutical company developing patient-friendly injectables for indications in diabetes, epilepsy, and immunology.
  • Website
    http://www.xerispharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $7,274,592
  • Transaction Round
    Series B
  • Proceeds Purposes
    Proceeds purposes were not disclosed. SEC regulatory filing. Contact technology company for investment details, if applicable. Not an offer or solicitation for sale of securities.
  • M&A Terms
  • Venture Investor

Trending on Xconomy